EPA
Omega 3 Benefits Patients in 4 Weeks
The
first study carried out by Peet and Horribin, was a randomised double
blind, placebo controlled trial carried out in Scotland, and involved
seventy patients who were suffering from depression that was persisting
despite ongoing treatment with standard antidepressant drugs. The trial
lasted twelve weeks, and the background anti depressant drugs the patients
were receiving were not altered during the trial, the results showed that
the patients taking EPA showed significant improvement, after only four
weeks, in all symptoms of depression, when compared to the placebo group.
Click here to go to the PuraEPA website.
|
|
